BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6125404)

  • 21. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
    Bhadada SV; Goyal RK
    Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of esmolol on airway function in patients with asthma.
    Sheppard D; DiStefano S; Byrd RC; Eschenbacher WL; Bell V; Steck J; Laddu A
    J Clin Pharmacol; 1986 Mar; 26(3):169-74. PubMed ID: 2870080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of pafenolol and metoprolol on ventilatory function and haemodynamics during exercise by asthmatic patients.
    Löfdahl CG; Marlin GE; Svedmyr N
    Eur J Clin Pharmacol; 1983; 24(3):289-95. PubMed ID: 6134621
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinicopharmacological studies on the bronchoconstrictive side effect of the beta-receptor blockader talinolol (Cordanum, 02-115) in patients with asthma or chronic obstructive lung diseases].
    Kandt D; Hackenberger F
    Pharmazie; 1975 Oct; 30(10):681-3. PubMed ID: 697
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.
    Philip-Joet F; Saadjian A; Bruguerolle B; Arnaud A
    Eur J Clin Pharmacol; 1986; 30(1):13-6. PubMed ID: 2872059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of the respiratory tolerance of adrenolytic beta-blockers in the asthmatic].
    Hugues FC; Julien D; Munera Y; Marche J
    Nouv Presse Med; 1978 Sep; 7(31):2711-5. PubMed ID: 30948
    [No Abstract]   [Full Text] [Related]  

  • 27. Ventilatory effects of ordinary and slow-release tablets of metoprolol in asthmatic patients.
    van den Bergh JH; van Herwaarden CL
    Eur J Respir Dis; 1981 Jun; 62(3):168-72. PubMed ID: 7308331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebivolol: a new beta blocker on the horizon.
    Katira R; Chauhan A
    Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
    Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
    Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of beta 1-selective beta blockers in patients with obstructive airway diseases].
    Vankov T
    ZFA (Stuttgart); 1983 Apr; 59(10):611-4. PubMed ID: 6135285
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bronchodilator properties of a vasodilator: cetiedil].
    Orehek J; Charpin D; Gayrard P; Grimaud Ch
    Nouv Presse Med; 1976 Jun; 5(25):1577-8. PubMed ID: 6947
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of beta-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy.
    Man in't Veld AJ; Boomsma F; Schalekamp MA
    Br J Clin Pharmacol; 1982; 13(Suppl 2):367S-374S. PubMed ID: 6125189
    [No Abstract]   [Full Text] [Related]  

  • 35. Pafenolol, a highly selective beta 1-adrenoceptor-antagonist, in asthmatic patients: interaction with terbutaline.
    Löfdahl CG; Marlin GE; Svedmyr N
    Clin Pharmacol Ther; 1983 Jan; 33(1):1-9. PubMed ID: 6129091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta-blocking and beta-stimulation in left ventricular failure].
    Waagstein F
    Lakartidningen; 1978 Nov; 75(47):4376-81. PubMed ID: 30870
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the effect on heart rate variability of some agents acting at the beta-adrenoceptor using nonlinear scatterplot and sequence methods.
    Silke B; Riddell JG
    Cardiovasc Drugs Ther; 1998 Oct; 12(5):439-48. PubMed ID: 9926274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A two year clinical evaluation of atenolol and metoprolol in the treatment of hypertension.
    Trafford JA; McGonigle R; Bowles J; O'Neal H; Bennet-Jones DN; Halford L
    Br J Clin Pract; 1982 Oct; 36(10):350-2. PubMed ID: 6756448
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
    Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
    Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cardiorespiratory effects of rimiterol and terbutaline aerosols.
    Harris L
    Bull Physiopathol Respir (Nancy); 1974; 10(6):801-10. PubMed ID: 4156915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.